Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
0.763
+0.037 (5.07%)
At close: Dec 20, 2024, 4:00 PM
0.769
+0.006 (0.83%)
After-hours: Dec 20, 2024, 7:52 PM EST
Precigen Revenue
Precigen had revenue of $953.00K in the quarter ending September 30, 2024, a decrease of -30.89%. This brings the company's revenue in the last twelve months to $3.96M, down -41.38% year-over-year. In the year 2023, Precigen had annual revenue of $6.23M, down -76.87%.
Revenue (ttm)
$3.96M
Revenue Growth
-41.38%
P/S Ratio
49.39
Revenue / Employee
$19,619
Employees
202
Market Cap
223.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6.23M | -20.68M | -76.87% |
| Dec 31, 2022 | 26.91M | 12.64M | 88.61% |
| Dec 31, 2021 | 14.27M | -17.73M | -55.40% |
| Dec 31, 2020 | 31.99M | -58.73M | -64.74% |
| Dec 31, 2019 | 90.72M | -60.46M | -39.99% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| biote | 193.06M |
| LifeMD | 193.06M |
| Fulcrum Therapeutics | 80.87M |
| Utah Medical Products | 44.08M |
| Zentalis Pharmaceuticals | 40.56M |
| Mersana Therapeutics | 34.84M |
| Profound Medical | 8.98M |
| Ocugen | 4.70M |
PGEN News
- 5 weeks ago - Precigen Reports Third Quarter 2024 Financial Results and Business Updates - PRNewsWire
- 5 weeks ago - Precigen to Participate in the Stifel 2024 Healthcare Conference - PRNewsWire
- 3 months ago - Precigen to Participate in the 2024 Cantor Global Healthcare Conference - PRNewsWire
- 4 months ago - Titan Machinery Reports Weak Preliminary Results, Joins Precigen, Gogoro And Other Big Stocks Moving Lower In Thursday Pre-Market Session - Benzinga
- 4 months ago - Precigen, Inc. (PGEN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates - PRNewsWire
- 4 months ago - Precigen to Announce Second Quarter and First Half 2024 Financial Results on August 14th - PRNewsWire
- 4 months ago - Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock - PRNewsWire